Roche Diagnostics: FDA 510(k) Clearances, Shared Predicate Lineage, and Recall History (1976 to 2026)

Consolidated U.S. FDA 510(k) premarket clearance cohort in Clinical Chemistry (primary filing hub: IN) reconciled with CDRH and openFDA historical recall notices from 1976 to 2026.

Review 1,155 FDA 510(k) clearances, 128 recalled K-numbers, and 296 cumulative 1976 to 2026 CDRH recall notices for Roche Diagnostics on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for Roche Diagnostics
Regulatory MetricVerified Value
Entity ClassificationConsolidated MedTech Parent (11 FDA applicant names)
Clinical Advisory SpecialtyClinical Chemistry (Panel CH)
Cleared FDA 510(k) Submissions (1976 to 2026)1,155 clearances (78 California, 6.8%)
Cleared 510(k)s Linked to a Recall Notice128 K-numbers (11.08% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)296 notices (34 Class I, 260 Class II, 2 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (296 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances1 implantable (0.1%) and 0 life-sustaining
Median FDA 510(k) Review Duration64 days (90th percentile: 238 days)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Roche / Genentech across sibling Meru public-data platforms.

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.